Malaria prevention in international travel;Prevención de la malaria en los viajes internacionales

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 5, 2003, Pages 248-260

  López Vélez, Rogelio ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Malaria; Prevention; Prophylaxis; Travel

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; CHLOROQUINE; CHLOROQUINE PLUS PROGUANIL; CIDOX; CLINDAMYCIN; DOCOSTYL; DOLQUINE; DOSIL; DOXICAT; DOXYCYCLINE; FANSIDAR; GLOXIL; HALOFANTRINE; MALARIA VACCINE; MALOPRIM; MEFLOQUINE; METAKELFIN; METOCLOPRAMIDE; PELEDOX; PRIMAQUINA; PRIMAQUINE; PRODERMA; PROGUANIL; PYRIMETHAMINE; QUININE; RETENS; REXILEN; TAFENOQUINE; TORASEPTOL; UNCLASSIFIED DRUG; VINZAN; ZENTAVON;

ANXIETY DISORDER; CHEMOPROPHYLAXIS; DEPRESSION; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; ESOPHAGITIS; GASTROINTESTINAL SYMPTOM; GEOGRAPHY; GLYCOGEN STORAGE DISEASE TYPE 1; HALLUCINATION; HEADACHE; HEMOLYTIC ANEMIA; HUMAN; INDIVIDUALIZATION; INFECTION PREVENTION; INFECTION RISK; INSECT BITE; INSOMNIA; INTERNATIONAL COOPERATION; LEUKOPENIA; LIVER FAILURE; MAJOR CLINICAL STUDY; MALARIA; METHEMOGLOBINEMIA; PARASITE IDENTIFICATION; PHOTOSENSITIVITY DISORDER; PSORIASIS; PSYCHOSIS; RASH; REVIEW; SELF REPORT; SIDE EFFECT; SPECIES IDENTIFICATION; TRAVEL; TREATMENT CONTRAINDICATION; VACCINE PRODUCTION; VAGINA CANDIDIASIS; VECTOR CONTROL; VERTIGO; VISUAL IMPAIRMENT; VOMITING;

EID: 0038206482     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13046544     Document Type: Review

References (74)

1. Malaria, 1982-1997. Wkly Epidemiol Rec 1999;74:265-70.
2. Muentener P, Schlagenhauf P, Steffen R. Imported malaria (1985-95): Trends and perspectives. Bull World Health Organ 1999;77:560-6.
3. Rotaeche V, Henández G, Mateo S. Vigilancia epidemiológica del paludismo en España: 1996-1999. Bol Epidemiol Semanal 2001:21-5.
4. López-Vélez R, Viana A, Pérez-Casas C, Martín-Aresti J, Turrientes MC, García-Camacho A. Clinicoepidemiological study of imported malaria in travelers and immigrants to Madrid. J Travel Med 1999;6:81-6.
5. Freedman DO, Woodall J. Emerging infectious diseases and risk to the traveler. Med Clin North Am 1999;83:865-83.
6. López-Vélez R, García Camacho A. Malaria, Africa y viajes: un triángulo de riesgo. Rev Clin Esp 1998;198:494-5.
7. Jelinek T, Nothdurft HD, Loscher T. Malaria in Nonimmune Travelers: A Synopsis of History, Symptoms, and Treatment in 160 Patients. J Travel Med 1994;1:199-202.
8. Bradley J, Warhurst D, Blaze M. Malaria imported into the United Kingdom in 1996. Euro Surveill 1998;3:40-2.
9. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002;347:13-8.
10. Conner BA. Expert recommendations for antimalarial prophylaxis. J Travel Med 2001;8(Suppl 3):S57-S64.
11. Schlagenhauf P. Mefloquine for malaria chemoprophylaxis 1992-1998: A review. J Travel Med 1999;6:122-33.
12. Croft AM, Garner P. Mefloquine for preventing malaria in non-immune adult travellers. Cochrane Database Syst Rev 2000:CD000138.
13. Schlagenhauf P, Tschopp A, Johnson R, Nothdurft HD, Beck B, Schwartz E, et al. Tolerability of malaria chemoprophylaxis in non-immune travellers; a randomized, double-blind, four arm study. Acta Tropica 2002;83:S39.
14. Keystone J, Kozarsky P. Closing the circle. En: SchlagenhaufP, editor. Traveler's malaria. Hamilton. Ontario: Dekker, 2001:510-5.
15. Kain KC, Shanks GD, Keystone JS. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. Clin Infect Dis 2001;33:226-34.
16. Shanks GD, Kain KC, Keystone JS. Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future. Clin Infect Dis 2001;33:381-5.
17. Shanks GD, Kremsner PG, Sukwa TY. Atovaquone and proguanil hydrochloride for prophylaxis of malaria. J Travel Med 1999;6(Suppl 1):21-7.
18. Ling J, Baird JK, Fryauff DJ, Sismadi P, Bangs MJ, Lacy M, et al. Randomized, Placebo-Controlled Trial of Atovaquone/Proguanil for the Prevention of Plasmodium falciparum or Plasmodium vivax Malaria among Migrants to Papua, Indonesia. PG - 825-33. Clin Infect Dis 2002;35:825-33.
19. Shapiro TA, Ranasinha CD, Kumar N, Barditch-Crovo P. Prophylactic activity of atovaquone against Plasmodium falciparum in humans. Am J Trop Med Hyg 1999;60:831-6.
20. Hogh B, Clarke PD, Camus D, Nothdurft HD, Overbosch D, Gunther M, et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: A randomized, double-blind study. Malarone International Study Team. Lancet 2000;356:1888-94.
21. Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, et al. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: Results from a randomized, double-blind study. Clin Infect Dis 2001;33:1015-21.
22. Kuschner RA, Heppner DG, Andersen SL, Wellde BT, Hall T, Schneider I, et al. Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum. Lancet 1994;343:1396-7.
23. Anderson SL, Berman J, Kuschner R, Wesche D, Magill A, Wellde B, et al. Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. Ann Intern Med 1995;123:771-3.
24. Taylor WR, Richie TL, Fryauff DJ, Picarima H, Ohrt C, Tang D, et al. Malaria prophylaxis using azithromycin: A double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin Infect Dis 1999;28:74-81.
25. Heppner D, Wongsrichanalai C, Walsh DS. Azithromycin for the prophylaxis of malaria in Thailand. Proceedings of the 48th Annual Meeting of the American Society of Tropical Medicine and Hygiene, nov 28-dec 2, 1999.
26. Orth C, Willingmyre GD, Lee P, Knirsch C, Millous W. Assessment of azithromycin in combination with other antimalarial drus against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 2002;46:2518-24.
27. Weiss WR, Oloo AJ, Johnson A, Koech D, Hoffman SL. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: Comparison with mefloquine, doxycycline, and chloroquine plus proguanil. J Infect Dis 1995;171:1569-75.
28. Ohrt C, Richie TL, Widjaja H, Shanks GD, Fitriadi J, Fryauff DJ, et al. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997;126:963-72.
29. Andersen SL, Oloo AJ, Gordon DM, Ragama OB, Aleman GM, Berman JD, et al. Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. Clin Infect Dis 1998;26:146-50.
30. Baudon D, Martet G, Pascal B, Bernard J, Keundjian A, Laroche R. Efficacy of daily antimalarial chemoprophylaxis in tropical Africa using either doxycycline or chloroquine-proguanil; a study conducted in 1996 in the French Army. Trans R Soc Trop Med Hyg 1999;93:302-3.
31. Shanks GD, Roessler P, Edstein MD, Rieckmann KH. Doxycycline for malaria prophylaxis in Australian soldiers deployed to United Nations missions in Somalia and Cambodia. Mil Med 1995;160:443-5.
32. Arthur JD, Echeverría P, Shanks GD, Karwacki J, Bodhidatta L, Brown JE. A comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria prophylaxis. Am J Trop Med Hyg 1990;43:608-13.
33. Steffen R, Fuchs E, Schildknecht J, Naef V, Funk M, Schlagenhauf P, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet 1993;341:1299-303.
34. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993;341:848-51.
35. Muehlberger N, Jelinek T, Schlipkoeter U, Von Sonnenburg F, Nothdurft HD. Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya. Trop Med Int Health 1998;3:357-63.
36. Hopperus Buma AP, Van Thiel PP, Lobel HO, Ohrt C, Van Ameijden EJ, Veltink RL, et al. Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia. J Infect Dis 1996;173:1506-9.
37. Lobel HO, Varma JK, Miani M, Green M, Tood GD, Grady K, et al. Monitoring for mefloquine-resistant Plasmodium falciparum in Africa: implications for travelers' health. Am J Trop Med Hyg 1998;59:129-32.
38. Wallace MR, Sharp TW, Smoak B, Iriye C, Rozmajzl P, Thornton SA, et al. Malaria among United States troops in Somalia. Am J Med 1996;100:49-55.
39. Boudreau E, Schuster B, Sánchez J, Novakowski W, Johnson R, Redmond D, et al. Tolerability of prophylactic Lariam regimens. Trop Med Parasitol 1993;44:257-65.
40. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: Postal and telephone survey of travellers. BMJ 1996;313:525-8.
41. Schlagenhauf P, Steffen R. Neuropsychiatric events and travel: Do antimalarials play a role? J Travel Med 2000;7:225-6.
42. Schlagenhauf P, Abo El, Ela H, Niederberger W. Drug safety database analysis of the events suicide, attempted suicide and suicidal ideation reported in association with the use of Lariam(r) chemoprophylaxis, Proceedings of the ISTM Conference, Innsbruck, may 27-31, 2001.
43. Phillips-Howard PA, Wood D. The safety of antimalarial drugs in pregnancy. Drug Saf 1996;14:131-45.
44. Vanhauwere B, Maradit H, Kerr L. Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy. Am J Trop Med Hyg 1998;58:17-21.
45. Smoak BL, Writer JV, Keep LW, Cowan J, Chantelois JL. The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen. J Infect Dis 1997;176:831-3.
46. Baird JK, Fryauff DJ, Basri H, Bangs MJ, Subianto B, Wiady I, et al. Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. Am J Trop Med Hyg 1995;52:479-84.
47. Baird JK, Lacy MD, Basri H, Barcus MJ, Maguire JD, Bangs MJ, et al. Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. Clin Infect Dis 2001;33:1990-7.
48. Fryauff DJ, Baird JK, Basri H, Sumawinata I, Purnomo, Richie TL, et al. Randomized placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 1995;346:1190-3.
49. Soto J, Toledo J, Rodriguez M, Sánchez J, Herrera H, Padilla J, et al. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers. Clin Infect Dis 1999;29:199-201.
50. Schwartz E, Regev-Yochay G. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline. Clin Infect Dis 1999;29:1502-6.
51. Lell B, Faucher JF, Missinou MA, Borrmann S, Dangelmaier O, Horton J, et al. Malaria chemoprophylaxis with tafenoquine: A randomized study. Lancet 2000;355:2041-5.
52. Shanks GD, Oloo AJ, Aleman GM, Ohrt C, Klotz FW, Braitman D, et al. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Clin Infect Dis 2001;33:1968-74.
53. CDC. Health information for international travel 2001-2002: US Department of Health and Human Services, Atlanta, 2001.
54. WHO. International Travel and Health. Situation as on 1 Juanary 2002: World Health Organization, Genève, 2002.
55. WHO. International Travel and Health. Situation as on 1 Juanary 2001: World Health Organization, Genève, 2001.
56. Bradley DJ, Bannister B. Guidelines for malaria prevention in travellers from the United Kingdom for 2001. Commun Dis Public Health 2001;4:84-101.
57. Pennie RA, Koren G, Crevoisier C. Steady state pharmacokinetics of mefloquine in long-term travellers. Trans R Soc Trop Med Hyg 1993;87:459-62.
58. Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991;45:86-91.
59. Rendi-Wagner P, Noedl H, Wernsdorfer WH, Wiedermann G, Mikolasek A, Kollaritsch H. Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults. Acta Trop 2002;81:167-73.
60. Drug alert: halofantrine. Wkly Epidemiol Rec 1993;68:269-70.
61. Matson PA, Luby SP, Redd SC, Rolka HR, Meriwether RA. Cardiac effects of standard-dose halofantrine therapy. Am J Trop Med Hyg 1996;54:229-31.
62. Jelinek T, Grobusch MP, Nothdurft HD. Use of dipstick tests for the rapid diagnosis of malaria in nonimmune travelers. J Travel Med 2000;7:175-9.
63. Behrens RH, Whitty CJ. Self-use of rapid tests for malaria diagnosis. Lancet 2000;355:237.
64. Bjorkman A, Phillips-Howard PA. Drug-resistant malaria: mechanisms of development and inferences for malaria control. Trans R Soc Trop Med Hyg 1990;84:323-4.
65. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2002;2:209-18.
66. Rieckmann KH, Davis DR, Hutton DC. Plasmodium vivax resistance to chloroquine? Lancet 1989;2:1183-4.
67. Schwartz IK, Lackritz EM, Patchen LC. Chloroquine-resistant Plasmodium vivax from Indonesia. N Engl J Med 1991;324:927.
68. Murphy GS, Basri H, Purnomo, Andersen EM, Bangs MJ, Mount DL, et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 1993;341:96-100.
69. Phillips EJ, Keystone JS, Kain KC. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis 1996;23:1171-3.
70. Baird JK, Wiady I, Fryauff DJ, Sutanihardja MA, Leksana B, Widjaya H, et al. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg 1997;56:627-31.
71. Fryauff DJ, Tuti S, Mardi A, Masbar S, Patipelohi R, Leksana B, et al. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am J Trop Med Hyg 1998;59:513-8.
72. Signorini L, Matteelli A, Castelnuovo F, Castelli F, Oladeji O, Carosi G. Short report: Primaquine-tolerant Plasmodium vivax in an Italian traveler from Guatemala. Am J Trop Med Hyg 1996;55:472-3.
73. Smoak BL, DeFraites RF, Magill AJ, Kain KC, Wellde BT. Plasmodium vivax infections in U.S. Army troops: Failure of primaquine to prevent relapse in studies from Somalia. Am J Trop Med Hyg 1997;56:231-4.
74. Maguire JD, Sumawinata IW, Masbar S, Leksana B, Prodjodipuro P, Susanti I, et al. Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia. Lancet 2002;360:58-60.